Flt3 ligand improves the innate response to respiratory syncytial virus and limits lung disease upon RSV reexposure in neonate mice

European Journal of Immunology

Volumn 46, Issue 4, 2016, Pages 874-884

  Remot, Aude ^a   Descamps, Delphyne ^a   Jouneau, Luc ^a   Laubreton, Daphné ^a   Dubuquoy, Catherine ^a   Bouet, Stephan ^a   Lecardonnel, Jérôme ^a   Rebours, Emmanuelle ^a   Petit Camurdan, Agnès ^a   Riffault, Sabine ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Dendritic cells; Flt3 L; Interferon; Lung; Neonate; Respiratory syncytial virus

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; FLT3 LIGAND; GAMMA INTERFERON; INTERFERON; INTERFERON REGULATORY FACTOR 7; INTERFERON REGULATORY FACTOR 9; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; VIRUS RNA; FLT3 LIGAND PROTEIN; MEMBRANE PROTEIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE EXACERBATION; GENE EXPRESSION; HEMATOPOIETIC CELL; HUMAN RESPIRATORY SYNCYTIAL VIRUS; INNATE IMMUNITY; LUNG DISEASE; MOUSE; NEWBORN; NEWBORN INFECTION; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RESPIRATORY TRACT DISEASE; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS; VIRUS LOAD; ANIMAL; BAGG ALBINO MOUSE; BRONCHIOLITIS, VIRAL; DENDRITIC CELL; DISEASE MODEL; DRUG EFFECTS; IMMUNOLOGY; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; TH1 CELL; VIROLOGY;

ANIMALS; ANIMALS, NEWBORN; BRONCHIOLITIS, VIRAL; CELL PROLIFERATION; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; IMMUNITY, INNATE; INTERFERON TYPE I; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; SIGNAL TRANSDUCTION; TH1 CELLS;

EID: 84962886214     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201545929     Document Type: Article

References (26)

1. Tregoning, J. S. and Schwarze, J., Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin. Microbiol. Rev. 2010. 23: 74-98.
2. Breese-Hall, C., Weinberg, G. A., Iwane, M. K., Blumkin, A. K., Edwards, K. M., Staat, M. A., Auinger, P. et al., The burden of respiratory syncytial virus infection in young children. N. Engl. J. Med. 2009. 360: 588-598.
3. Lambert, L., Sagfors, A., Openshaw, P. and Culley, F., Immunity to RSV in early-life. Front Immunol. 2014. 5: 466, 1-14.
4. Mejias, A., Dimo, B., Suarez, N., Garcia, C., Suarez-Arrabal, M., Jartti, T., Blankenship, D. et al., Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection. PLoS Med. 2013. 10: e1001549.
5. Legg, J., Hussain, I., Warner, J., Johnston, S. and Warner, J., Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am. J. Respir. Crit. Care Med. 2003. 168: 633-639.
6. Perez-Yarza, E., Moreno, A., Lazaro, P., Mejias, A. and Ramilo, O., The association between respiratory syncytial virus infection and the development of childhood asthma: a systematic review of the literature. Pediatr. Infect Dis. J. 2007. 26: 733-739.
7. Busse, W. W., Lemanske, R. F. and Gern, J. E., Role of viral respiratory infections in asthma and asthma exacerbations. Lancet 2010. 376: 826-834.
8. Culley, F. J., Pollott, J. and Openshaw, P. J. M., Age at first viral infection determines the pattern of t cell-mediated disease during reinfection in adulthood. J. Exp. Med. 2002. 196: 1381-1386.
9. Cormier, S. A., You, D. and Honnegowda, S., The use of a neonatal mouse model to study respiratory syncytial virus infections. Expert. Rev. Anti. Infect. Ther. 2010. 8: 1371-1380.
10. Tregoning, J. S., Yamaguchi, Y., Harker, J., Wang, B. and Openshaw, P. J., The role of T cells in the enhancement of respiratory syncytial virus infection severity during adult reinfection of neonatally sensitized mice. J. Virol. 2008. 82: 4115-4124.
11. Roux, X., Remot, A., Petit-Camurdan, A., Nahori, M. A., Kiefer-Biasizzo, H., Marchal, G., Lagranderie, M. and Riffault, S., Neonatal lung immune responses show a shift of cytokines and transcription factors toward Th2 and a deficit in conventional and plasmacytoid dendritic cells. Eur. J. Immunol. 2011. 41: 2852-2861.
12. Willems, F., Vollstedt, S. and Suter, M., Phenotype and function of neonatal DC. Eur. J. Immunol. 2009. 39: 26-35.
13. Wang, H. W., Lu, J. Y., Wang, L. and Tian, G., In vivo administration of Fms-like tyrosine kinase-3 ligand effectively stimulates lung dendritic cell expansion in mice. Chin. Med. J. 2012. 125: 2562-2567.
14. Vollstedt, S., O'Keeffe, M., Odermatt, B., Beat, R., Glanzmann, B., Riesen, M., Shortman, K. and Suter, M., Treatment of neonatal mice with Flt3 ligand leads to changes in dendritic cell subpopulations associated with enhanced IL-12 and IFN-α production. Eur. J. Immunol. 2004. 34: 1849-1860.
15. Rameix-Welti, M., Le Goffic, R., Hervé, P., Sourimant, J., Remot, A., Riffault, S., Yu, Q. et al., Visualizing the replication of respiratory syncytial virus in cells and in living mice. Nat. Commun. 2014. 5: 5104.
16. Cormier, S., Shrestha, B., Saravia, J., Lee, G., Shen, L., DeVincenzo, J., Kim, Y. and You, D., Limited type I interferons and plasmacytoid dendritic cells during neonatal respiratory syncytial virus infection permit immunopathogenesis upon reinfection. J. Virol. 2014. 88: 9350-9360.
17. Goritzka, M., Durant, L., Pereira, C., Salek-Ardakani, S., Openshaw, P. and Johansson, C., Alpha/beta interferon receptor signaling amplifies early proinflammatory cytokine production in the lung during respiratory syncytial virus infection. J. Virol. 2014. 88: 6128-6136.
18. You, D., Becnel, D., Wang, K., Ripple, M., Daly, M. and Cormier, S. A., Exposure of neonates to respiratory syncytial virus is critical in determining subsequent airway response in adults. Respir. Res. 2006. 7: 107.
19. Jewell, N. A., Vaghefi, N., Mertz, S. E., Akter, P., Peebles, R. S., Jr., Bakaletz, L. O., Durbin, R. K. et al., Differential type I interferon induction by respiratory syncytial virus and influenza a virus in vivo. J. Virol. 2007. 81: 9790-9800.
20. Goritzka, M., Makris, S., Kausar, F., Durant, L., Pereira, C., Kumagai, Y., Culley, F. et al., Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes. J. Exp. Med. 2015. 212: 699-714.
21. Ruckwardt, T., Malloy, A., Morabito, K. and Graham, B., Quantitative and qualitative deficits in neonatal lung-migratory dendritic cells impact the generation of the CD8+ T cell response. PLoS Pathog. 2014. 10: e1003934.
22. Smit, J. J., Lindell, D. M., Boon, L., Kool, M., Lambrecht, B. N. and Lukacs, N. W., The balance between plasmacytoid DC versus conventional DC determines pulmonary immunity to virus infections. PloS One 2008. 3: e1720.
23. Yamaguchi, Y., Harker, J. A., Wang, B., Openshaw, P. J., Tregoning, J. S. and Culley, F. J., Pre-exposure to CpG protects against the delayed effects of neonatal RSV infection. J. Virol. 2012. 86: 10456-10461.
24. Edwan, J., Perry, G., Talmadge, J. and Agrawal, D., Flt-3 ligand reverses late allergic response and airway hyper-responsiveness in a mouse model of allergic inflammation. J. Immunol. 2004. 172: 5016-5023.
25. Remot, A., Roux, X., Dubuquoy, C., Fix, J., Bouet, S., Moudjou, M., Eleouet, J. F., Riffault, S. and Petit-Camurdan, A., Nucleoprotein nanostructures combined with adjuvants adapted to the neonatal immune context: a candidate mucosal RSV vaccine. PloS One 2012. 7: e37722.
26. Empey, K. M., Orend, J. G., Peebles, R. S., Egaña, L., Norris, K. A., Oury, T. D. and Kolls, J. K., Stimulation of immature lung macrophages with intranasal interferon gamma in a novel neonatal mouse model of respiratory syncytial virus infection. PloS One 2012. 7: e40499.